VuCOMP Inc. has received market clearance for both M-Vu CAD and M-Vu Breast Density in Turkey.

August 21, 2014 — IDS announced that Desert Imaging (DI) of El Paso, Texas, has implemented IDS’ AbbaDox RAD cloud-based radiology IT platform to manage imaging workflow for its growing multisite imaging practice. DI’s two outpatient imaging centers and mobile mammography suites are benefitting from AbbaDox RAD’s seamlessly integrated RIS (radiology information system), PACS (picture archiving and communications system), Voice2Dox speech recognition clinical reporting, referring physician portal and CRM to expand their referral base.

August 21, 2014 — Christie Medical Holdings and Wolfson Children’s Hospital announced an agreement to replace all current peripheral vascular access visualization devices at the hospital with 17 VeinViewers through Christie's FreshStart program.

Avreo partnered with Roper St. Francis to provide services in 18 clinics across 36 locations throughout the Charleston, S.C., area. 

Mindray and Zonare recently teamed together to provide 17 ultrasound systems to Hennepin County Medical Center (HCMC) in Minneapolis — a nationally recognized regional healthcare provider.

Shimadzu is facing stiff competition as other players in the market narrow the performance gap and widen their provider loyalty bases. KLAS' 2014 DR mobile report looks at how vendors are performing side by side, why some are edging ahead, and what providers see as the gaps.

August 20, 2014 — MRI Interventions Inc. announced that neurosurgeons at UC San Diego Health System have utilized the ClearPoint system's platform capabilities to facilitate three same-setting MRI (magnetic resonance imaging)-guided neurosurgical procedures for a single patient.

August 20, 2014 — Additive manufacturing (3-D printing) company Oxford Performance Materials (OPM) announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its 3-D printed OsteoFab patient-specific facial device.

NorthStar Medical Radioisotopes LLC signed a non-exclusive letter of intent with GE Healthcare, a division of General Electric Co., marking further progress toward establishing the first existing commercially viable domestic source of the radioisotope 99molybdenum (99Mo).

 

GE Healthcare introduces the Vscan with Dual Probe with the first of its kind 2-in-1 probe to give healthcare providers more uses for pocket ultrasound.

Subscribe Now